Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds
Thus, only 1300 cm 3 of plasma was removed versus 2600 cm 3
With consistent use, many users notice a visible improvement in skin tone and tightness
Jozwiak M, et al
[PMID: 36206677] PubMed record related to this compound for laboratory literature review
US$ 26.09
)
)
US$ 25.87
US$ 29.38
US$ 27.49
